A detailed history of Boston Family Office LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Boston Family Office LLC holds 8,694 shares of BSX stock, worth $773,331. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,694
Previous 8,444 2.96%
Holding current value
$773,331
Previous $650,000 12.15%
% of portfolio
0.05%
Previous 0.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $18,240 - $21,000
250 Added 2.96%
8,694 $729,000
Q2 2024

Aug 12, 2024

SELL
$67.33 - $77.71 $6,733 - $7,770
-100 Reduced 1.17%
8,444 $650,000
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $28,800 - $34,310
-500 Reduced 5.53%
8,544 $585,000
Q4 2023

Feb 12, 2024

SELL
$48.64 - $57.81 $8,171 - $9,712
-168 Reduced 1.82%
9,044 $523,000
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $15,057 - $16,404
-300 Reduced 3.15%
9,212 $486,000
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $2,734 - $3,005
-55 Reduced 0.57%
9,512 $514,000
Q1 2023

May 10, 2023

SELL
$45.09 - $50.03 $317,884 - $352,711
-7,050 Reduced 42.43%
9,567 $478,000
Q3 2022

Nov 08, 2022

SELL
$36.71 - $109.66 $7,415 - $22,151
-202 Reduced 1.2%
16,617 $644,000
Q2 2022

Aug 11, 2022

BUY
$35.24 - $47.1 $38,940 - $52,045
1,105 Added 7.03%
16,819 $627,000
Q1 2022

May 11, 2022

BUY
$40.9 - $45.1 $199,183 - $219,637
4,870 Added 44.91%
15,714 $696,000
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $162,363 - $180,675
-3,938 Reduced 26.64%
10,844 $471,000
Q2 2021

Aug 12, 2021

SELL
$38.58 - $44.24 $108,024 - $123,872
-2,800 Reduced 15.93%
14,782 $632,000
Q1 2021

May 07, 2021

SELL
$35.27 - $39.67 $263,572 - $296,453
-7,473 Reduced 29.83%
17,582 $692,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $173,208 - $219,293
-5,225 Reduced 17.26%
25,055 $901,000
Q1 2020

May 11, 2020

SELL
$25.83 - $45.71 $284,130 - $502,810
-11,000 Reduced 26.65%
30,280 $988,000
Q4 2019

Feb 05, 2020

SELL
$37.87 - $45.37 $45,444 - $54,444
-1,200 Reduced 2.82%
41,280 $1.87 Million
Q3 2019

Nov 12, 2019

BUY
$40.31 - $43.45 $43,333 - $46,708
1,075 Added 2.6%
42,480 $1.73 Million
Q2 2019

Jul 30, 2019

BUY
$34.91 - $42.98 $3,490 - $4,298
100 Added 0.24%
41,405 $1.78 Million
Q1 2019

May 09, 2019

BUY
$32.91 - $40.75 $55,124 - $68,256
1,675 Added 4.23%
41,305 $1.59 Million
Q4 2018

Feb 12, 2019

BUY
$31.73 - $39.04 $67,426 - $82,960
2,125 Added 5.67%
39,630 $1.4 Million
Q3 2018

Nov 01, 2018

BUY
$32.83 - $38.63 $9,192 - $10,816
280 Added 0.75%
37,505 $1.44 Million
Q2 2018

Jul 26, 2018

SELL
$26.84 - $34.32 $71,797 - $91,806
-2,675 Reduced 6.7%
37,225 $1.22 Million
Q1 2018

Apr 30, 2018

SELL
$25.2 - $28.54 $40,950 - $46,377
-1,625 Reduced 3.91%
39,900 $1.09 Million
Q4 2017

Feb 06, 2018

SELL
$24.79 - $29.8 $50,199 - $60,345
-2,025 Reduced 4.65%
41,525 $1.03 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $1.14 Million - $1.27 Million
43,550
43,550 $1.27 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.